CA2022460A1 - Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments - Google Patents

Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments

Info

Publication number
CA2022460A1
CA2022460A1 CA002022460A CA2022460A CA2022460A1 CA 2022460 A1 CA2022460 A1 CA 2022460A1 CA 002022460 A CA002022460 A CA 002022460A CA 2022460 A CA2022460 A CA 2022460A CA 2022460 A1 CA2022460 A1 CA 2022460A1
Authority
CA
Canada
Prior art keywords
general formula
radical
preparation
medicaments
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002022460A
Other languages
English (en)
French (fr)
Inventor
Jose Miguel Ribalta-Baro
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of CA2022460A1 publication Critical patent/CA2022460A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CA002022460A 1989-08-04 1990-08-01 Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments Abandoned CA2022460A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8910537A FR2650589A1 (fr) 1989-08-04 1989-08-04 Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments
FR8910537 1989-08-04

Publications (1)

Publication Number Publication Date
CA2022460A1 true CA2022460A1 (fr) 1991-02-05

Family

ID=9384485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022460A Abandoned CA2022460A1 (fr) 1989-08-04 1990-08-01 Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments

Country Status (16)

Country Link
US (1) US5132304A (cg-RX-API-DMAC7.html)
EP (1) EP0412014A1 (cg-RX-API-DMAC7.html)
JP (1) JP2566843B2 (cg-RX-API-DMAC7.html)
KR (1) KR950009827B1 (cg-RX-API-DMAC7.html)
CA (1) CA2022460A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ277710B6 (cg-RX-API-DMAC7.html)
DD (1) DD296920A5 (cg-RX-API-DMAC7.html)
ES (1) ES2023760A6 (cg-RX-API-DMAC7.html)
FR (1) FR2650589A1 (cg-RX-API-DMAC7.html)
HU (1) HU210064B (cg-RX-API-DMAC7.html)
PL (1) PL164340B1 (cg-RX-API-DMAC7.html)
PT (1) PT94904A (cg-RX-API-DMAC7.html)
RO (1) RO107657B1 (cg-RX-API-DMAC7.html)
RU (1) RU2032679C1 (cg-RX-API-DMAC7.html)
YU (1) YU47562B (cg-RX-API-DMAC7.html)
ZA (1) ZA905995B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053395B1 (es) * 1992-11-16 1995-02-16 S A L V A T Lab Sa "4-cinnamoiloxi-2-metil-n-(2-piridil)-2h-1,2-benzotiazina-3-carboxamida 1,1-dioxido, procedimiento para la obtencion del mismo y nuevos intermedios utilizados en su preparacion.
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
AU727905B2 (en) * 1996-01-17 2001-01-04 Novo Nordisk A/S Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
US6297260B1 (en) 1998-10-30 2001-10-02 Nitromed, Inc. Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923801A (en) * 1974-09-23 1975-12-02 Mcneilab Inc Oxazinobenzothiazine 6,6-dioxides
US3925371A (en) * 1974-09-23 1975-12-09 Mcneilab Inc Benzothiazine-1,1-dioxides
US3900470A (en) * 1974-09-23 1975-08-19 Mcneilab Inc Esters of benzothiazine-1,1-dioxides derivatives
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
FR2597103B1 (fr) * 1986-04-15 1988-12-16 Provesan Sa Procede de preparation de derives d'oxazinobenzothiazine 6,6-dioxyde

Also Published As

Publication number Publication date
ES2023760A6 (es) 1992-02-01
YU150690A (sh) 1992-09-07
FR2650589A1 (fr) 1991-02-08
RO107657B1 (ro) 1993-12-30
CS384690A3 (en) 1992-08-12
DD296920A5 (de) 1991-12-19
PT94904A (pt) 1991-04-18
HUT58733A (en) 1992-03-30
HU210064B (en) 1995-01-30
JP2566843B2 (ja) 1996-12-25
PL164340B1 (pl) 1994-07-29
ZA905995B (en) 1991-07-31
HU904885D0 (en) 1991-01-28
CZ277710B6 (en) 1993-03-17
EP0412014A1 (fr) 1991-02-06
RU2032679C1 (ru) 1995-04-10
KR950009827B1 (ko) 1995-08-29
US5132304A (en) 1992-07-21
JPH0366687A (ja) 1991-03-22
YU47562B (sh) 1995-10-03
KR910004614A (ko) 1991-03-29
FR2650589B1 (cg-RX-API-DMAC7.html) 1994-04-22
PL286340A1 (en) 1992-01-13

Similar Documents

Publication Publication Date Title
EP1248771B1 (fr) Procede de preparation de derives de l'acide 3-hydroxypicolinique
EP0283390B1 (fr) Dérivés du thiazole actifs sur le système cholinergique, procédé d'obtention et compositions pharmaceutiques en contenant
FR2692893A1 (fr) Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
EP0834508A1 (fr) Nouveaux dérivés substitués de biphényle ou de phénylpyridine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0462264A1 (fr) Derives heterocycliques, leur procede de preparation et leur application therapeutique comme antagonistes du paf.
EP0611766A1 (fr) Dérivés de 2-amido-thiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament
EP0143123B1 (fr) Produits industriels nouveaux utilisés notamment comme intermédiaires dans la préparation de nouveaux dérivés du 4-hydroxy 3-quinoléine carboxamide substitués en 2 et la préparation desdits intermédiaires
EP0526313B1 (fr) Nouveaux dérivés de l'urée, leur préparation et leur application en thérapeutique
EP0533827B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0348257A2 (fr) Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique
EP0002978B1 (fr) Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique
EP0374041A1 (fr) Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation
EP0573318A1 (fr) Nouveaux dérivés de phényle carboxamide isoxazoles et leurs sels, leur procédé de préparation et les nouveaux intermédiaires de ce procédé, leur application comme médicaments et les compositions pharmaceutiques les renfermant
CA2022460A1 (fr) Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments
EP0099770B1 (fr) Nouveaux dérivés d'oxazinobenzothiazine-6,6-dioxyde, leur préparation et leur application en tant que médicaments
EP0463944A1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0242289B1 (fr) Procédé de préparation de dérivés d'oxazinobenzothiazine 6,6-dioxyde
EP0196943B1 (fr) Nouveaux dérivés 8-thiotétrahydroquinoléines et leurs sels
LU85780A1 (fr) Nouveaux esters enoliques precurseurs de medicaments et composition pharmaceutique les contenant
WO2007068815A2 (fr) Derives heterocycliques, leur preparation et leur application en therapeutique.
MC1135A1 (fr) Derives de thiazine
RU2069212C1 (ru) Производные имидазола
FR2636327A1 (fr) Derives de quinoleine, leurs procedes de preparation et les medicaments les contenant
EP0502110B1 (fr) Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique
MC593A1 (fr) Nouveaux benzène sulfonyl-semicarbazides et leur préparation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued